Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antigen Clearance
14%
Antigen-antibody
14%
Cellular Processes
14%
Chronic Hepatitis B
14%
Chronic Hepatitis B Patients
100%
Expression Profile
28%
Global Health Issue
14%
Health Care Costs
14%
Hepatitis B Surface Antigen (HBsAg)
100%
Hepatitis e Antigen
28%
Hepatitis Surface Antigen
14%
Immunogenic
14%
Kinetic Expression
14%
Large Cohort
14%
Let-7f
28%
MicroRNA
100%
MicroRNA Profile
100%
MiR-122
28%
MiR-22
28%
MiR-30a
28%
Non-responders
28%
Personalized Treatment
28%
Phase III Clinical Trial
14%
Prognostic Value
14%
Seroconversion
14%
Serum microRNA
42%
Therapeutic Efficacy
14%
Therapeutic Vaccination
28%
Therapeutic Vaccine
100%
Treatment Course
14%
Treatment Response
14%
Vaccine Effectiveness
100%
Variation Trend
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cellular Processes
9%
Chronic Hepatitis B
100%
Clinical Trial
9%
Combination Therapy
9%
Diseases
9%
Hepatitis B Antigen
100%
Membrane Antigen
9%
microRNA
100%
microRNA 122
18%
microRNA 22
18%
Therapeutic Vaccine
100%
Vaccine Efficacy
100%
Immunology and Microbiology
HBsAg
100%
Hepatitis B
100%
Hepatitis B Antigen
100%
Hepatitis B Vaccine
16%
Immune Complex
16%
Membrane Antigen
16%
Seroconversion
16%
Vaccine Efficacy
100%
Biochemistry, Genetics and Molecular Biology
Antigen Antibody Complex
9%
Clinical Trial
9%
HBsAg
100%
MicroRNA
100%
Mir-22
18%
Seroconversion
9%